ELEX Biotech
Portland · Founded 2009
About ELEX Biotech
ELEX Biotech develops small-molecule pharmaceutical drugs for the management and cure of cardiovascular diseases such as heart failure and arrhythmias, enabling physicians to offer effective treatments for heart-related diseases. These compounds modulate the function of calcium channels that control the contraction of cardiac muscle.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.4M
- Last round: Grant (Nov 2014)
- Website: https://www.elexbiotech.com
- Phone: +1 503-488-5870
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/elex-biotech-2248093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.